Loading organizations...
§ Private Profile · Taipei, T'ai-pei, Taiwan
Biotechnology research firm focused on cancer treatment innovation.
HanchorBio has raised $20.0M across 1 funding round.
HanchorBio has raised $20.0M in total across 1 funding round.
HanchorBio has raised $20.0M in total across 1 funding round.
HanchorBio's investors include Sino Biopharmaceutical, Zero2IPO.
HanchorBio has raised $20.0M across 1 funding round. Most recently, it raised $20.0M Series A in August 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Aug 25, 2022 | $20M Series A | Sino Biopharmaceutical | Zero2IPO | Announced |